Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by LithLoveron Jan 27, 2022 1:35pm
135 Views
Post# 34367472

RE:Pre split low’s

RE:Pre split low’s The largest shareholder is now Health Clinics. I can't see them wanting a r/s given their acquisition was all in shares.  The same for wanting more dilution through additional rounds of financing. 

You would think the best scenario for them is to help drive revenue to improve the share price or failing that to garner enouih interest to obtain a buyout so they receive the $2 a share that was part of the agreement.  

As the largest shareholder I can't see them just sitting back and allowing splits, dillution etc without pushing revenue or working on a buy out.  Richard is now on the board.

Our mesely share count doesn't come close to what they hold and assuming the AVRT shares and UK shares get added thats a total of 12,400,000 + 8,000,000 +2,500,000 = 22,900,000.

A potential 23 million shares, I'm sure they want the share price to increase organically worse than us.  



brad129 wrote: Seems like the reverse split has really achieved nothing, we are currently at the low prior to the split, let's all remember this when they want to do another one.


<< Previous
Bullboard Posts
Next >>